ADMA Biologics, Inc. (ADMA) Ownership

$0.00

$0 (0%)
Last update: 07:00 PM EST
Day's range
$15.05
Day's range
$15.92

Adma Biologics Inc Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
BLACKROCK, INC. 08/07/2026 38.36 M $321.04 M   4.14% 16.81%
STATE STREET CORP 09/22/2026 17.12 M $143.26 M   21.53% 7.25%
VANGUARD CAPITAL MANAGEMENT LLC 08/13/2026 10.10 M $84.57 M   -1.97% 4.43%
VANGUARD PORTFOLIO MANAGEMENT LLC 08/13/2026 10.09 M $84.44 M   13.75% 4.42%
RUBRIC CAPITAL MANAGEMENT LP 08/14/2026 9.34 M $78.17 M   416.16% 4.09%
CAPITAL RESEARCH GLOBAL INVESTORS 08/12/2026 8.76 M $73.29 M   -21.76% 3.84%
FIRST TRUST ADVISORS LP 08/11/2026 7.80 M $65.27 M   2,064.90% 3.42%
GEODE CAPITAL MANAGEMENT, LLC 08/12/2026 6.06 M $50.73 M   4.05% 2.66%
CALIGAN PARTNERS LP 08/14/2026 5.73 M $47.92 M   20.36% 2.51%
D. E. SHAW & CO., INC. 08/14/2026 5.27 M $44.15 M   840.50% 2.31%
DIMENSIONAL FUND ADVISORS LP 08/11/2026 3.61 M $30.18 M   -27.95% 1.58%
GOLDMAN SACHS GROUP INC 08/14/2026 3.51 M $29.41 M   25.33% 1.54%
B GROUP, INC. 08/14/2026 3.26 M $27.31 M   1.71% 1.43%
NUVEEN, LLC 08/11/2026 3.26 M $27.29 M   -46.54% 1.43%
DUQUESNE FAMILY OFFICE LLC 08/14/2026 2.78 M $23.30 M   80.13% 1.22%
NORTHERN TRUST CORP 08/13/2026 2.42 M $20.22 M   6.09% 1.06%
NANTAHALA CAPITAL MANAGEMENT, LLC 08/19/2026 2.36 M $19.75 M   100.00% 1.03%
MORGAN STANLEY 08/13/2026 2.27 M $18.96 M   -6.94% 0.99%
RANGER INVESTMENT MANAGEMENT, L.P. 08/13/2026 2.12 M $17.71 M   -7.37% 0.93%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 08/14/2026 2.09 M $17.52 M   -0.15% 0.92%
SIXTH STREET PARTNERS MANAGEMENT COMPANY, L.P. 08/14/2026 2.09 M $17.52 M   100.00% 0.92%
TWO SIGMA INVESTMENTS, LP 08/14/2026 2.02 M $16.91 M   -3.45% 0.89%
KENNEDY CAPITAL MANAGEMENT LLC 08/14/2026 1.76 M $14.69 M   326.68% 0.77%
VANGUARD FIDUCIARY TRUST CO 08/13/2026 1.65 M $13.85 M   1.04% 0.73%
FUNDSMITH LLP 08/14/2026 1.65 M $13.81 M   0.00% 0.72%
BANK OF AMERICA CORP /DE/ 08/14/2026 1.65 M $13.79 M   -58.78% 0.72%
PRICE T ROWE ASSOCIATES INC /MD/ 08/14/2026 1.59 M $13.33 M   -28.15% 0.70%
AQR CAPITAL MANAGEMENT LLC 08/14/2026 1.53 M $12.77 M   196.35% 0.67%
LIFE CYCLE INVESTMENT PARTNERS LTD 08/13/2026 1.52 M $12.75 M   100.00% 0.67%
BNP PARIBAS ARBITRAGE, SNC 08/13/2026 1.45 M $12.17 M   -23.68% 0.64%
PRINCIPAL FINANCIAL GROUP INC 08/04/2026 1.38 M $11.55 M   -0.76% 0.60%
CITADEL ADVISORS LLC 09/02/2026 1.37 M $11.47 M   -76.42% 0.60%
CLEARLINE CAPITAL LP 08/14/2026 1.33 M $11.17 M   140.04% 0.58%
QUBE RESEARCH & TECHNOLOGIES LTD 08/14/2026 1.32 M $11.02 M   -28.04% 0.58%
BANK OF NEW YORK MELLON CORP 08/06/2026 1.25 M $10.47 M   -7.73% 0.55%
NATIONAL PHILANTHROPIC TRUST 08/14/2026 1.20 M $10.01 M   100.00% 0.52%
BOOTHBAY FUND MANAGEMENT, LLC 08/14/2026 1.18 M $9.85 M   18.63% 0.52%
UBS GROUP AG 08/13/2026 1.17 M $9.82 M   -45.45% 0.51%
MILLENNIUM MANAGEMENT LLC 08/14/2026 1.15 M $9.66 M   -66.39% 0.51%
FEDERATED HERMES, INC. 08/12/2026 1.01 M $8.49 M   -40.35% 0.44%
CAPTION MANAGEMENT, LLC 08/14/2026 1.00 M $8.37 M   -12.92% 0.44%
DEUTSCHE BANK AG\ 08/07/2026 976.61 K $8.17 M   4.90% 0.43%
ROYAL BANK OF CANADA 08/14/2026 880.33 K $7.37 M   -5.27% 0.39%
PUBLIC SECTOR PENSION INVESTMENT BOARD 08/13/2026 796.22 K $6.66 M   -6.48% 0.35%
ALGERT GLOBAL LLC 08/13/2026 777.19 K $6.51 M   118.35% 0.34%
STONEPINE CAPITAL MANAGEMENT, LLC 08/17/2026 740.00 K $6.19 M   0.00% 0.32%
RUSSELL INVESTMENTS GROUP, LTD. 08/06/2026 727.88 K $6.09 M   2.27% 0.32%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 08/14/2026 686.92 K $5.75 M   -32.76% 0.30%
HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND 08/13/2026 667.00 K $5.58 M   100.00% 0.29%
JANE STREET GROUP, LLC 08/14/2026 662.08 K $5.54 M   -78.31% 0.29%

Adma Biologics Inc institutional Ownership - FAQ's

During the previous two years, 474 institutional investors and hedge funds held shares of Adma Biologics Inc. The most heavily invested institutionals were:

City Center Advisors, LLC: 37,628

GAMMA Investing LLC: 6,119

Farther Finance Advisors, LLC: 3,181

MASSMUTUAL TRUST CO FSB/ADV: 338

Versant Capital Management, Inc: 112

Davis Capital Management: 13

89.99% of Adma Biologics Inc stock is owned by institutional investors.

Institutional investors have bought a total of 259.04 M shares in the last 24 months. This purchase volume represents approximately $4.10 B in transactions.